CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,305,352 | -13.0% | 111,664 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $1,500,764 | -18.9% | 111,664 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $1,851,389 | +74432.6% | 111,664 | -16.4% | 0.00% | -50.0% |
Q4 2022 | $2,484 | -99.9% | 133,568 | -54.1% | 0.00% | -33.3% |
Q3 2022 | $3,732,000 | +83.0% | 290,897 | 0.0% | 0.00% | +200.0% |
Q2 2022 | $2,039,000 | -5.6% | 290,897 | +11.7% | 0.00% | 0.0% |
Q1 2022 | $2,159,000 | +20.1% | 260,468 | -1.9% | 0.00% | 0.0% |
Q4 2021 | $1,798,000 | +68.0% | 265,552 | +31.6% | 0.00% | 0.0% |
Q3 2021 | $1,070,000 | – | 201,801 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |